Status:
COMPLETED
Group Psychotherapy in Narcolepsy Type 1
Lead Sponsor:
Cantonal Hospital of St. Gallen
Conditions:
Narcolepsy Type 1
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this pilot study is to test the benefit of behavior therapy-oriented, method-integrated psychotherapy in an outpatient group setting in patients with narcolepsy type 1. Therefore we collect...
Eligibility Criteria
Inclusion
- Diagnosed narcolepsy type 1 according to AASM, examined by an experienced sleep physician including history, clinical examination, polysomnographic examination (PSG) with a multiple sleep latency test (MSLT), possibly also including determination of HLA DQB1 \* 062 and orexin A / hypocretin 1
- Age between 18 and 65 years
- Signed informed consent
- Exclusion of other clinically relevant organic sleep disorders by means of polysomnography (AHI\>10/h)
Exclusion
- Presence of severe psychiatric comorbidity
- Other psychotherapy during the study period
- Change of medication used for narcolepsy therapy shortly before the start and during the study period including follow-up measurement. In this case, patients may still complete group therapy, but the data will not be included in the analysis.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05314556
Start Date
August 1 2021
End Date
December 31 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for Psychosomatic Medicine, Cantonal Hospital St.Gallen
Sankt Gallen, Switzerland, 9000